Login / Signup

Author Response: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.

Salter AmberSamantha LanciaKaarina KowalecKathryn C FitzgeraldKathryn C Fitzgerald
Published in: Neurology (2024)
Keyphrases
  • multiple sclerosis
  • clinical trial
  • risk factors
  • phase ii
  • white matter
  • open label
  • double blind
  • study protocol
  • genetic diversity
  • phase iii